5 Jun'26 Portfolio
Increasing exposure to healthcare and REITs
Vish (Hunting Alphas)
Credo: Optics Ramp, Margin Upside And Bullish Charts Point To More Upside (Archive)
Credo’s optics ramp, margin expansion, and technicals still justify a bullish buy rating.
Portfolio Performance - May'26
May'26: ~7.5% annualized alpha, Sortino 2.0, IR 0.67, low max drawdowns. Live, real-money portfolio.
Alphabet Is Managing AI Capex Well And Seems Highly Underrated (Archive)
Alphabet’s aggressive AI capex and equity raise are mispriced, leaving shares clearly undervalued.
Broadcom Q2: Undervalued After The Post-Earnings Selloff (Archive)
There's AI capex scrutiny and margin pressure, but valuation discount supports patient holders.
29 May'26 Portfolio
Ramping up software exposure
Palo Alto Networks: Why It's Worth Buying Before June 2 (Archive)
PANW looks good before Q3 earnings to capture strong growth despite demanding valuation backdrop.